Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Doximity (DOCS) Change in Receivables (2020 - 2025)

Doximity (DOCS) has disclosed Change in Receivables for 6 consecutive years, with $27.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Receivables rose 112.64% to $27.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $19.3 million, a 52.8% decrease, with the full-year FY2025 number at $27.2 million, up 781.34% from a year prior.
  • Change in Receivables was $27.6 million for Q4 2025 at Doximity, up from -$12.4 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $32.4 million in Q1 2023 to a low of -$14.0 million in Q2 2023.
  • A 5-year average of $5.8 million and a median of $4.5 million in 2023 define the central range for Change in Receivables.
  • Peak YoY movement for Change in Receivables: skyrocketed 3579.65% in 2021, then tumbled 401.9% in 2025.
  • Doximity's Change in Receivables stood at $14.0 million in 2021, then plummeted by 128.5% to -$4.0 million in 2022, then soared by 128.4% to $1.1 million in 2023, then soared by 1044.14% to $13.0 million in 2024, then soared by 112.64% to $27.6 million in 2025.
  • Per Business Quant, the three most recent readings for DOCS's Change in Receivables are $27.6 million (Q4 2025), -$12.4 million (Q3 2025), and $13.4 million (Q2 2025).